Caplight Directory>Investors>Hankang Capital>Hankang-capital


H

Hankang Capital

Shanghai, Shanghai

Overview

Hankang Capital, established in 2010, is a corporate venture capital firm of Zhongjianxin Group headquartered in Shanghai, China . The firm focuses on investments in sectors like biomedicine, medical equipment, diagnostic reagents, medical services, and other major health fields .

Year Founded

2010

Portfolio Companies

12

Investments

CompanyDateStageLead
Vivacta Biotechnology (Shanghai) Co., Ltd.Apr 2026Series ACo-investor
Pinnacle MedicinesMar 2026Series BCo-investor
Shanghai Leadingtac Pharmaceutical Co., Ltd.Dec 2025Series BLead
Phrontline BiopharmaNov 2025pre_series_a_plusCo-investor
AusperBioSep 2025Series B ExtensionCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2010

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.